Dr. Capeding led the first Phase 3 trial ever completed for a dengue vaccine candidate.

This blog post was originally published on Making Malaria History. 
 
Anyone working in global health will say the same thing: the people impacted by

Nigeria, Africa’s most populous country, more than doubled its immunization budget from 2010-2012 and that budget continues to grow.

This blog was originally posed on the Dengue Vaccine Initiative website
 
This year’s Americas Dengue Prevention Board (DPB)

Dr. Jon Andrus Named Executive Vice President of the Sabin Vaccine Institute

WASHINGTON, D.C. — September 25, 2014 — The Sabin Vaccine Institute (Sabin) today announced that effective October 17, 2014, Dr. Jon Andrus will join Sabin as Executive Vice President and Director of Vaccine Advocacy and Education. In this role, he will leverage more than three decades of experience as a global health leader with a well-documented record for fostering collaboration among national governments and partners to expand access to vaccines for the world’s poorest people.

Pages

Subscribe to RSS - Vaccine Advocacy and Education